Top 100 honour for LanzaTech

CATHERINE HARRIS
Last updated 07:55 07/02/2013

Relevant offers

Industries

Spark, Vodafone confirm trans-Tasman cable plan Arvida slips after NZX debut at 97c NZ GDP grew 1 per cent, beats expectations Trends Publishing defends $332K Callaghan grant Kirkcaldies' boss John Milford to head Business Central Lines company may sell BOP investment Connor reapplies for takeover approval Angry investors tackle Pyne Gould Corp Air NZ legal victory over surcharge appealed Sharebroker eyes civil action against South Canterbury Finance

New Zealand-founded biotech star LanzaTech has been named one of America's brightest commercial hopes by Forbes magazine.

Now headquartered in Illinois, LanzaTech was ranked 48th in the magazine's Top 100 list of the most promising US private firms.

It was the only clean energy or bioscience firm in the top 50.

LanzaTech chief executive Jennifer Holmgren said the magazine mention was a huge honour and "validation of our approach to reducing emissions through innovative technology and solid partnerships".

LanzaTech retains its research and development base in New Zealand and co-founder Sean Simpson remains chief scientific officer.

It has received worldwide attention for its use of microbes to convert industrial- waste gas containing carbon monoxide into fuels and chemicals.

In August, the company was one of 23 "technology pioneers" named by the World Economic Forum for its potential to impact on the future.

LanzaTech is also working with Virgin to produce jet fuel, and with Malaysian petrol giant Petronas to turn gases containing carbon dioxide into acetic acid.

However, its most recent milestone was becoming the first company to scale up gas fermentation technology to a pre- commercial level. It achieved this with Chinese steel maker Baosteel.

Ad Feedback

- BusinessDay.co.nz

Special offers

Featured Promotions

Sponsored Content